Hello. Today's Nasdaq story from Daily Stock focuses on the government contract trends of Palantir (PLTR), a leading AI software and big data analytics company in the United States.
[Image: /stdaily/uploads/202608/gen_6a6d37785b2575.26559916.png]
Executive Summary
Palantir (PLTR) continues to achieve high growth backed by strong trust from the US government and defense sectors, but it also faces critical assessments and noise surrounding its government contracts.
Key drivers proving its robust fundamentals include the $10 billion framework contract signed with the US Army in 2025 and the expansion of Project MAVEN.
However, skepticism regarding the contract extension with the UK's National Health Service (NHS) and intensifying competition in international public sector contracts are cited as potential headwinds for Palantir's future valuation multiples.
Market & Current Situation
As of today (2026-08-01), the domestic stock market stands at 6,595.45 for the KOSPI and 719.76 for the KOSDAQ, with the USD/KRW exchange rate closing at 1,444.30 won.
While the KOSPI Fear & Greed Index swings between Fear (23.7) today and Extreme Fear (13.5) a week ago, the US Nasdaq index stands at 25,373.85 points.
With no price confirmation for the day (based on the latest confirmed closing price of $122.44 on July 31, 2026), anticipation is building ahead of Palantir's Q2 earnings release scheduled after the market close on August 3.
Meanwhile, the US Nasdaq Fear & Greed Index points to Neutral (42.5) today and Neutral (41.3) a week ago, reflecting ongoing valuation adjustments across global tech stocks.
Recent controversies over the effectiveness of its patient discharge tracking software within the UK's NHS, coupled with allegations of preferential non-competitive bidding from the UK Ministry of Defence (MoD), have slightly weakened the psychological support level.
Nevertheless, large-scale IT modernization contract wins with the US Treasury Department and its sovereign AI partnership with Nvidia provide strong downside protection.
Financial Analysis
Palantir's government segment revenue still accounts for approximately 54% of its total revenue, solidly serving as the company's core cash cow.
According to the upcoming Q2 guidance, quarterly revenue is projected to reach up to $1.801 billion, representing roughly 79% year-over-year growth.
| Classification | FY2025 Annual Results (Confirmed) | Q2 2026 Outlook (Guidance) |
|---|---|---|
| **Revenue** | Approx. $4.48 billion | $1.797 billion - $1.801 billion |
| **Operating Income** | Approx. $1.41 billion | $1.063 billion - $1.067 billion (Adjusted) |
| **Net Income** | Approx. $1.63 billion | Expected EPS: $0.33 - $0.35 |
| **Cash and Short-term Investments** | Approx. $8.03 billion (Recent Q) | TBD |
Thanks to the long-term nature of government contracts, margins remain highly resilient in the mid-to-high 80% range, among the highest in the software industry.
However, the key highlight of this earnings report will be how successfully the high growth in the commercial sector offsets the gradual growth deceleration in the government sector.
Valuation
Currently, Palantir's forward Price-to-Sales (P/S) ratio stands at around 60x, demanding one of the most expensive multiples in the software industry.
While it commands a premium due to its unique AI data Ontology architecture, the multiple has normalized somewhat from its historical peak of 100x.
[Image: /stdaily/uploads/202608/gen_6a6d378138a5e4.03005535.png]
Its scarcity as a military platform becoming the standard software for the US Department of Defense is the strongest argument supporting the floor of its multiple.
However, if rate cut expectations recede or volatility in the US 10-year Treasury yield (US10Y) increases, stock price turbulence typical of high-valuation equities remains a potential risk.
Expert & Institutional Analysis
Many Wall Street institutions evaluate that Palantir's government contracts have entered a "lock-in phase" within national intelligence infrastructures, rather than being mere temporary budget expenditures.
The 10-year, $10 billion Enterprise Services Agreement (ESA) with the US Army announced last year suggests that Palantir's software has effectively been selected as the standard.
On the other hand, conservative analysts, including those at Morningstar, cite fairness disputes from sole-source contracts and geopolitical exclusivity in the European market as key risks.
They advise closely monitoring resistance against US-monopolized software as European Union nations, including France, promote local data analytics firms.
Risk Factors
The most fundamental risk is that public sector contracts are extremely vulnerable to political climates and geopolitical noise.
Recent reports from health advocacy groups questioning the tangible performance of the UK NHS contract could serve as strong leverage against Palantir in future European government bids.
Furthermore, large-scale insider selling by key executives whenever the stock price recovers puts pressure on investor sentiment.
If government sector growth fails to meet market expectations, pre-priced concerns over an AI bubble could trigger short-term profit-taking.
Investment Outlook
Its portfolio of long-term contracts with the US Army and intelligence agencies provides Palantir with firm financial resilience that remains intact even during economic downturns.
At the same time, it possesses a conditional duality where its dominance as a defense AI standard becomes more secure as geopolitical risks intensify.
[Image: /stdaily/uploads/202608/gen_6a6d378b28afb1.87123186.png]
Ultimately, the earnings release on August 3 will serve as a stage to prove not just a simple earnings surprise, but the stability of its government contracts and the smooth landing of its commercial pipeline.
Rather than chasing rallies, it is reasonable for investors to monitor the Volatility Index (VIX) and US Treasury yields, adopting a long-term portfolio diversification approach.
FAQ
Q1. Will Palantir's $10 billion contract with the US Army be recognized as immediate revenue?
A1. No.
This is a "limit-guaranteed framework" agreement that allows the Army and related DoD agencies to seamlessly purchase Palantir systems over the next 10 years, with revenue recognized in parts based on actual orders.
Q2. What is the specific issue regarding the recent UK National Health Service (NHS) contract controversy?
A2. A recent Health Foundation report stated that the patient discharge system's impact on reducing wait times has not been proven.
As a result, political pressure is building from opposition parties and civic groups to trigger the contract termination clause by 2027.
Q3. Is commercial revenue growing alongside government revenue?
A3. Yes.
US commercial business has shown triple-digit year-over-year growth, emerging as a key growth driver that significantly buffers the slower growth in the government sector.
Q4. How does the recent partnership with Nvidia relate to government contracts?
A4. The two companies are collaborating to accelerate the deployment of "Sovereign AI" infrastructure and specialized models designed to meet the stringent security requirements of global public and defense sectors.
Q5. Where does Palantir's stock price stand relative to its recent peak?
A5. Compared to its all-time high of around $207 recorded at the end of 2025, it is currently trading in the low $120s, a correction of about 40%.
This trend reflects the broader valuation multiple contraction across the software industry.